Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7370)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Eslamparast T, Eghtesad S, Poustchi H, Hekmatdoost A. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 204-212 [PMID: 25729475 DOI: 10.4254/wjh.v7.i2.204] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i2/204.htm |
| Number | Citing Articles |
| 1 |
Mohammed A. E. Naiel, Samar S. Negm, Shakira Ghazanfar, Mustafa Shukry, Sameh A. Abdelnour. The risk assessment of high‐fat diet in farmed fish and its mitigation approaches: A review. Journal of Animal Physiology and Animal Nutrition 2023; 107(3): 948 doi: 10.1111/jpn.13759
|
| 2 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 129 doi: 10.1007/978-94-007-7675-3_1
|
| 3 |
Ewa Stachowska, Karina Ryterska, Dominika Maciejewska, Marcin Banaszczak, Piotr Milkiewicz, Małgorzata Milkiewicz, Izabela Gutowska, Piotr Ossowski, Małgorzata Kaczorowska, Dominika Jamioł-Milc, Anna Sabinicz, Małgorzata Napierała, Lidia Wądołowska, Joanna Raszeja-Wyszomirska. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). International Journal of Molecular Sciences 2016; 17(7): 1192 doi: 10.3390/ijms17071192
|
| 4 |
Ludovico Abenavoli. Non-alcoholic fatty liver disease and beneficial effects of dietary supplements. World Journal of Hepatology 2015; 7(12): 1723-1724 doi: 10.4254/wjh.v7.i12.1723
|
| 5 |
Mina Darand, Zahra Darabi, Zahra Yari, Saeedeh Saadati, Mehdi Hedayati, Ahmad Khoncheh, Behnam Hosseini-Ahangar, Seyed moayyed Alavian, Azita Hekmatdoost. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial. Complementary Therapies in Medicine 2019; 44: 204 doi: 10.1016/j.ctim.2019.04.014
|
| 6 |
Carmen Lara Romero, Lucía López Bermudo, Miguel Fernández Gómez, Andrea Cornejo, Genoveva Berná, Manuel Romero-Gómez. Comprehensive Guide to Hepatitis Advances. 2023; : 343 doi: 10.1016/B978-0-323-98368-6.00019-7
|
| 7 |
Mehrnaz Nikkhah Bodagh, Iradj Maleki, Azita Hekmatdoost. Ginger in gastrointestinal disorders: A systematic review of clinical trials. Food Science & Nutrition 2019; 7(1): 96 doi: 10.1002/fsn3.807
|
| 8 |
Huaguo Chen, Lei Peng, Chao Zhao, Zongwei Cai, Xin Zhou. Protective Mechanism of Polygonum perfoliatum L. Extract on Chronic Alcoholic Liver Injury Based on UHPLC-QExactive Plus Mass Spectrometry Lipidomics and MALDI-TOF/TOF Mass Spectrometry Imaging. Foods 2022; 11(11): 1583 doi: 10.3390/foods11111583
|
| 9 |
Ming Yue Wang, Kousalya Prabahar, Mihnea‐Alexandru Găman, Jin Lin Zhang. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta‐analysis on randomized controlled trials. Journal of Digestive Diseases 2023; 24(6-7): 380 doi: 10.1111/1751-2980.13210
|
| 10 |
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. BMJ Open 2017; 7(7): e016914 doi: 10.1136/bmjopen-2017-016914
|
| 11 |
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Advances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
|
| 12 |
Fangyuan Dong, Yan Zhang, Yiqin Huang, Yiqian Wang, Gansheng Zhang, Xiaona Hu, Jiaofeng Wang, Jie Chen, Zhijun Bao. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Scientific Reports 2016; 6(1) doi: 10.1038/srep36783
|
| 13 |
Negin Kamari, Mehdi Moradinazar, Mahmoud Qasemi, Tina Khosravy, Mehnoosh Samadi, Hadi Abdolahzad. Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial. Food Science & Nutrition 2023; 11(4): 1846 doi: 10.1002/fsn3.3218
|
| 14 |
Parissa Sadat Ghoreishi, Mesbah Shams, Majid Nimrouzi, Mohammad M. Zarshenas, Kamran Bagheri Lankarani, Ebrahim Fallahzadeh Abarghooei, Mozaffar Talebzadeh, Mohammad Hashem Hashempur.
The Effects of Ginger (
Zingiber Officinale
Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial
. Journal of Dietary Supplements 2024; 21(3): 294 doi: 10.1080/19390211.2023.2263788
|
| 15 |
Emanuela Esposito, Michela Campolo, Marika Cordaro, Giovanna Casili, Salvatore Cuzzocrea. Autophagy Networks in Inflammation. 2016; : 365 doi: 10.1007/978-3-319-30079-5_17
|
| 16 |
Zeinab Mokhtari, Hossein Poustchi, Tannaz Eslamparast, Azita Hekmatdoost. Egg consumption and risk of non-alcoholic fatty liver disease. World Journal of Hepatology 2017; 9(10): 503-509 doi: 10.4254/wjh.v9.i10.503
|
| 17 |
Nasrindokht Zamani, Mesbah Shams, Majid Nimrouzi, Mohammad Mehdi Zarshenas, Amin Abolhasani Foroughi, Ebrahim Fallahzadeh Abarghooei, Mohammad Reza Fattahi. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial. Complementary Therapies in Medicine 2018; 41: 118 doi: 10.1016/j.ctim.2018.09.010
|
| 18 |
Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World Journal of Gastroenterology 2021; 27(37): 6161-6179 doi: 10.3748/wjg.v27.i37.6161
|
| 19 |
Yingying Yan, Wenhui Zhang. Potentilla anserina L. attenuates oleic acid-induced steatosis in HepG2 cells and hyperlipidemia in high fat diet-induced obese mice. Journal of Functional Foods 2023; 109: 105772 doi: 10.1016/j.jff.2023.105772
|
| 20 |
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?. Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
|
| 21 |
Yaron Ilan. Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?. Digestive Diseases and Sciences 2018; 63(7): 1726 doi: 10.1007/s10620-018-5080-x
|
| 22 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_1-1
|
| 23 |
Human Microbiome in Health and Disease - Part A. Progress in Molecular Biology and Translational Science 2022; 191: 187 doi: 10.1016/bs.pmbts.2022.07.004
|
| 24 |
Vickram Beejmohun, Cyril Mignon, Aude Mazollier, Marie Peytavy-Izard, Dominique Pallet, Manuel Dornier, Nicolas Chapal. Cashew apple extract inhibition of fat storage and insulin resistance in the diet-induced obesity mouse model. Journal of Nutritional Science 2015; 4 doi: 10.1017/jns.2015.30
|
| 25 |
Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Mithun Sharma, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. World Journal of Hepatology 2016; 8(20): 827-837 doi: 10.4254/wjh.v8.i20.827
|
| 26 |
Seyed Mohammad Tabatabaee, Seyed Moayed Alavian, Leila Ghalichi, Seyed Mohammad Miryounesi, Kazem Mousavizadeh, Shima Jazayeri, Mohammad Reza Vafa. Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Hepatitis Monthly 2017; 17(12) doi: 10.5812/hepatmon.14993
|
| 27 |
Reyhaneh Yousefi, Atoosa Saidpour, Azadeh Mottaghi. The effects of Spirulina supplementation on metabolic syndrome components, its liver manifestation and related inflammatory markers: A systematic review. Complementary Therapies in Medicine 2019; 42: 137 doi: 10.1016/j.ctim.2018.11.013
|
| 28 |
Soonwoong Jung, Hyeonwi Son, Chung Eun Hwang, Kye Man Cho, Sang Won Park, Hwajin Kim, Hyun Joon Kim. The Root of Polygonum multiflorum Thunb. Alleviates Non-Alcoholic Steatosis and Insulin Resistance in High Fat Diet-Fed Mice. Nutrients 2020; 12(8): 2353 doi: 10.3390/nu12082353
|
| 29 |
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Journal of the American College of Nutrition 2018; 37(3): 223 doi: 10.1080/07315724.2017.1392264
|
| 30 |
Xiao-jun Gou, Shanshan Gao, Liang Chen, Qin Feng, Yi-yang Hu. A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5920485
|
| 31 |
Dyari H. Ahmed, Hawal Lateef Fateh. Impact of Flaxseed Supplementation on Lipid Profile and Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prostaglandins & Other Lipid Mediators 2024; : 106838 doi: 10.1016/j.prostaglandins.2024.106838
|
| 32 |
Zahra Darabi, Mina Darand, Zahra Yari, Mehdi Hedayati, Amirhosein Faghihi, Shahram Agah, Azita Hekmatdoost. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial. BMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4130-6
|
| 33 |
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
|
| 34 |
Mehran Rahimlou, Zahra Yari, Azita Hekmatdoost, Seyed Moayed Alavian, Seyed Ali Keshavarz. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hepatitis Monthly 2016; 16(1) doi: 10.5812/hepatmon.34897
|
| 35 |
Azita Hekmatdoost, Ali Shamsipour, Mohammad Meibodi, Newsha Gheibizadeh, Tannaz Eslamparast, Hossein Poustchi. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease. International Journal of Food Sciences and Nutrition 2016; 67(8): 1024 doi: 10.1080/09637486.2016.1210101
|
| 36 |
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiota. Molecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
|
| 37 |
Karishma Naidoo, Andile Khathi. The Potential Role of Gossypetin in the Treatment of Diabetes Mellitus and Its Associated Complications: A Review. International Journal of Molecular Sciences 2023; 24(24): 17609 doi: 10.3390/ijms242417609
|
| 38 |
Khadijeh Abhari, Saeede Saadati, Zahra Yari, Hedayat Hosseini, Mehdi Hedayati, Shahabeddin Abhari, Seyyed Moayyed Alavian, Azita Hekmatdoost. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. Clinical Nutrition ESPEN 2020; 39: 53 doi: 10.1016/j.clnesp.2020.06.020
|
| 39 |
Asal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, Zahra Yari, Ghazal Daftari, Amin Salehpour, Mehdi Hedayati, Elmira Khalili, Seyed Ahmad Hosseini, Azita Hekmatdoost. The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55747-6
|
| 40 |
Maryam Noori, Bahar Jafari, Azita Hekmatdoost. Pomegranate juice prevents development of non‐alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. Journal of the Science of Food and Agriculture 2017; 97(8): 2327 doi: 10.1002/jsfa.8042
|
| 41 |
Zeinab Mokhtari, Deanna L Gibson, Azita Hekmatdoost. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Advances in Nutrition 2017; 8(2): 240 doi: 10.3945/an.116.013151
|
| 42 |
John E. Lewis, Steven E. Atlas, Oscar L. Higuera, Andrea Fiallo, Ammar Rasul, Ashar Farooqi, Olga Kromo, Laura A. Lantigua, Eduard Tiozzo, Judi M. Woolger, Sharon Goldberg, Armando Mendez, Allan E. Rodriguez, Janet Konefal. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/1751583
|
| 43 |
Yolanda Sánchez-Torrijos, Leticia Álvarez-Amor, Rocío Aller, Pedro Pablo García-Luna, Franz Martín, Manuel Romero-Gómez. Non-Alcoholic Fatty Liver Disease. 2020; : 271 doi: 10.1007/978-3-319-95828-6_15
|
| 44 |
Hadi Emamat, Forough Foroughi, Hassan Eini–Zinab, Mohsen Taghizadeh, Marjan Rismanchi, Azita Hekmatdoost. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. Journal of Diabetes & Metabolic Disorders 2015; 15(1) doi: 10.1186/s40200-016-0248-4
|
| 45 |
Zahra Yari, Mehran Rahimlou, Tannaz Eslamparast, Naser Ebrahimi-Daryani, Hossein Poustchi, Azita Hekmatdoost. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. International Journal of Food Sciences and Nutrition 2016; 67(4): 461 doi: 10.3109/09637486.2016.1161011
|
| 46 |
Alessandro Federico, Marcello Dallio, Giuseppe Caprio, Antonietta Gravina, Desiree Picascia, Mario Masarone, Marcello Persico, Carmela Loguercio. Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. Nutrients 2017; 9(10): 1074 doi: 10.3390/nu9101074
|
| 47 |
Xianlin Han. Lipidomics for studying metabolism. Nature Reviews Endocrinology 2016; 12(11): 668 doi: 10.1038/nrendo.2016.98
|
| 48 |
Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca Valenti. Nutritional therapy for nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2016; 29: 1 doi: 10.1016/j.jnutbio.2015.08.024
|
| 49 |
Hadi Emamat, Hossein Farhadnejad, Hossein Poustchi, Farshad Teymoori, Alireza Bahrami, Azita Hekmatdoost. The association between dietary acid load and odds of non-alcoholic fatty liver disease: A case-control study. Nutrition and Health 2023; 29(4): 637 doi: 10.1177/02601060221088383
|
| 50 |
Govindaraj Jayanthy Balachander, Sorimuthupillai Subramanian, Kaliappan Ilango. Rosmarinic acid attenuates hepatic steatosis by modulating ER stress and autophagy in oleic acid-induced HepG2 cells. RSC Advances 2018; 8(47): 26656 doi: 10.1039/C8RA02849D
|
| 51 |
Hadi Emamat, Forough Foroughi, Hassan Eini-Zinab, Azita Hekmatdoost. The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease. Indian Journal of Clinical Biochemistry 2018; 33(1): 75 doi: 10.1007/s12291-017-0636-7
|
| 52 |
Emma T. Saltzman, Talia Palacios, Michael Thomsen, Luis Vitetta. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00061
|
| 53 |
Alessio Carmignani, Matteo Battaglini, Martina Bartolucci, Andrea Petretto, Mirko Prato, Gianni Ciofani. Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease. Materials & Design 2024; 239: 112825 doi: 10.1016/j.matdes.2024.112825
|
| 54 |
Shooka Mohammadi, Damoon Ashtary‐Larky, Omid Asbaghi, Vida Farrokhi, Yasaman Jadidi, Fatemeh Mofidi, Mehrnaz Mohammadian, Reza Afrisham. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose–response meta‐analysis. Phytotherapy Research 2024; doi: 10.1002/ptr.8173
|
| 55 |
Zahra Safari, Philippe Gérard. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cellular and Molecular Life Sciences 2019; 76(8): 1541 doi: 10.1007/s00018-019-03011-w
|
| 56 |
Martins IJ. Indian spices and Caffeine treatment for Obesity and Cardiovascular disease. Annals of Clinical Endocrinology and Metabolism 2017; 2(1): 010 doi: 10.29328/journal.acem.1001005
|
| 57 |
V. Sorrenti, C. Di Giacomo, R. Acquaviva, J. Cosenza, G. Carota, F. Galvano. Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway. RSC Advances 2019; 9(20): 11406 doi: 10.1039/C9RA00669A
|
| 58 |
Zeinab Ghorbani, Masoomeh Hajizadeh, Azita Hekmatdoost. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary & Pancreatic Diseases International 2016; 15(4): 348 doi: 10.1016/S1499-3872(16)60096-6
|